These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

574 related items for PubMed ID: 17845537

  • 1. Serum C-reactive protein levels predict survival in hepatocellular carcinoma.
    Nagaoka S, Yoshida T, Akiyoshi J, Akiba J, Torimura T, Adachi H, Kurogi J, Tajiri N, Inoue K, Niizeki T, Koga H, Imaizumi T, Kojiro M, Sata M.
    Liver Int; 2007 Oct; 27(8):1091-7. PubMed ID: 17845537
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Prognostic values of alpha-fetoprotein and protein induced by vitamin K absence or antagonist-II in hepatitis B virus-related hepatocellular carcinoma: a prospective study.
    Kim HS, Park JW, Jang JS, Kim HJ, Shin WG, Kim KH, Lee JH, Kim HY, Jang MK.
    J Clin Gastroenterol; 2009 Oct; 43(5):482-8. PubMed ID: 19197197
    [Abstract] [Full Text] [Related]

  • 4. The des-gamma-carboxy prothrombin index is a new prognostic indicator for hepatocellular carcinoma.
    Nagaoka S, Yatsuhashi H, Hamada H, Yano K, Matsumoto T, Daikoku M, Arisawa K, Ishibashi H, Koga M, Sata M, Yano M.
    Cancer; 2003 Dec 15; 98(12):2671-7. PubMed ID: 14669288
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. P21/WAF1 is an independent survival prognostic factor for patients with hepatocellular carcinoma after resection.
    Kao JT, Chuah SK, Huang CC, Chen CL, Wang CC, Hung CH, Chen CH, Wang JH, Lu SN, Lee CM, Changchien CS, Hu TH.
    Liver Int; 2007 Aug 15; 27(6):772-81. PubMed ID: 17617120
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Initial treatment response is essential to improve survival in patients with hepatocellular carcinoma who underwent curative radiofrequency ablation therapy.
    Takahashi S, Kudo M, Chung H, Inoue T, Ishikawa E, Kitai S, Tatsumi C, Ueda T, Minami Y, Ueshima K, Haji S.
    Oncology; 2007 Aug 15; 72 Suppl 1():98-103. PubMed ID: 18087189
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Significance of serum hepatocyte growth factor levels in patients with hepatocellular carcinoma undergoing hepatic resection.
    Chau GY, Lui WY, Chi CW, Chau YP, Li AF, Kao HL, Wu CW.
    Eur J Surg Oncol; 2008 Mar 15; 34(3):333-8. PubMed ID: 17218078
    [Abstract] [Full Text] [Related]

  • 13. High serum des-gamma-carboxy prothrombin level predicts poor prognosis after radiofrequency ablation of hepatocellular carcinoma.
    Kobayashi M, Ikeda K, Kawamura Y, Yatsuji H, Hosaka T, Sezaki H, Akuta N, Suzuki F, Suzuki Y, Saitoh S, Arase Y, Kumada H.
    Cancer; 2009 Feb 01; 115(3):571-80. PubMed ID: 19117347
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Staging hepatocellular carcinoma by a novel scoring system (BALAD score) based on serum markers.
    Toyoda H, Kumada T, Osaki Y, Oka H, Urano F, Kudo M, Matsunaga T.
    Clin Gastroenterol Hepatol; 2006 Dec 01; 4(12):1528-36. PubMed ID: 17162244
    [Abstract] [Full Text] [Related]

  • 16. Postoperative peak serum C-reactive protein predicts outcome of hepatic resection for hepatocellular carcinoma.
    Shiba H, Furukawa K, Fujiwara Y, Futagawa Y, Haruki K, Wakiyama S, Ishida Y, Misawa T, Yanaga K.
    Anticancer Res; 2013 Feb 01; 33(2):705-9. PubMed ID: 23393371
    [Abstract] [Full Text] [Related]

  • 17. PIVKA-II is the best prognostic predictor in patients with hepatocellular carcinoma after radiofrequency ablation therapy.
    Takahashi S, Kudo M, Chung H, Inoue T, Ishikawa E, Kitai S, Tatsumi C, Ueda T, Nagai T, Minami Y, Ueshima K.
    Oncology; 2008 Feb 01; 75 Suppl 1():91-8. PubMed ID: 19092277
    [Abstract] [Full Text] [Related]

  • 18. Chemoembolization for hepatocellular carcinoma: multivariate analysis of predicting factors for tumor response and survival in a 362-patient cohort.
    Hu HT, Kim JH, Lee LS, Kim KA, Ko GY, Yoon HK, Sung KB, Gwon DI, Shin JH, Song HY.
    J Vasc Interv Radiol; 2011 Jul 01; 22(7):917-23. PubMed ID: 21571545
    [Abstract] [Full Text] [Related]

  • 19. Elevated serum vitamin B(12) levels in association with tumor markers as the prognostic factors predictive for poor survival in patients with hepatocellular carcinoma.
    Lin CY, Kuo CS, Lu CL, Wu MY, Huang RF.
    Nutr Cancer; 2010 Jul 01; 62(2):190-7. PubMed ID: 20099193
    [Abstract] [Full Text] [Related]

  • 20. The effect of preoperative transarterial chemoembolization of resectable hepatocellular carcinoma on clinical and economic outcomes.
    Lee KT, Lu YW, Wang SN, Chen HY, Chuang SC, Chang WT, Shi HY, Ker CG, Chiu HC.
    J Surg Oncol; 2009 May 01; 99(6):343-50. PubMed ID: 19226530
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 29.